Literature DB >> 12525289

Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis.

Richard D. Pearson1.   

Abstract

Entities:  

Year:  2003        PMID： 12525289     DOI： 10.1007/s11908-003-0063-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  7 in total

1.  Short-course of oral miltefosine for treatment of visceral leishmaniasis.

Authors:  S Sundar; A Makharia; D K More; G Agrawal; A Voss; C Fischer; P Bachmann; H W Murray
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

2.  Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.

Authors:  J Soto; J Toledo; P Gutierrez; R S Nicholls; J Padilla; J Engel; C Fischer; A Voss; J Berman
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

3.  Oral treatment of visceral leishmaniasis with miltefosine.

Authors:  S Sundar; L B Gupta; M K Makharia; M K Singh; A Voss; F Rosenkaimer; J Engel; H W Murray
Journal:  Ann Trop Med Parasitol       Date:  1999-09

4.  Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.

Authors:  T K Jha; S Sundar; C P Thakur; P Bachmann; J Karbwang; C Fischer; A Voss; J Berman
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

5.  Oral miltefosine for Indian visceral leishmaniasis.

Authors:  Shyam Sundar; T K Jha; C P Thakur; Juergen Engel; Herbert Sindermann; Christina Fischer; Klaus Junge; Anthony Bryceson; Jonathan Berman
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

6.  Trial of oral miltefosine for visceral leishmaniasis.

Authors:  S Sundar; F Rosenkaimer; M K Makharia; A K Goyal; A K Mandal; A Voss; P Hilgard; H W Murray
Journal:  Lancet       Date:  1998-12-05       Impact factor: 79.321

7.  The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani.

Authors:  S L Croft; R A Neal; W Pendergast; J H Chan
Journal:  Biochem Pharmacol       Date:  1987-08-15       Impact factor: 5.858
  7 in total
  2 in total

1.  Possible mechanism of miltefosine-mediated death of Leishmania donovani.

Authors:  Navin K Verma; Chinmoy S Dey
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.

Authors:  Juan Fernando Alzate; Andrés Arias; Faustino Mollinedo; Eva Rico; Janis de la Iglesia-Vicente; Antonio Jiménez-Ruiz
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.